SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-006785 to BLOOMIOS, INC. (CIK 0001138608)

BLOOMIOS, INC. (CIK 0001138608)
Date: June 26, 2023 · CIK: 0001138608 · Accession: 0000000000-23-006785

AI Filing Summary & Sentiment

File numbers found in text: 333-272762

Date
June 26, 2023
Author
Not clearly detected
Form
UPLOAD
Company
BLOOMIOS, INC. (CIK 0001138608)

Letter

United States securities and exchange commission logo June 26, 2023 Barrett Evans President Bloomios, Inc. 701 Anacapa Street, Suite C Santa Barbara, CA 93101 Re:Bloomios, Inc. Registration Statement on Form S-1 Filed June 20, 2023 File No. 333-272762 Dear Barrett Evans: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ken Bart

Show Raw Text
United States securities and exchange commission logo
June 26, 2023
Barrett Evans
President
Bloomios, Inc.
701 Anacapa Street, Suite C
Santa Barbara, CA 93101
Re:Bloomios, Inc.
Registration Statement on Form S-1
Filed June 20, 2023
File No. 333-272762
Dear Barrett Evans:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Ken Bart